TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer
Authors
Keywords
-
Journal
GENE THERAPY
Volume 17, Issue 4, Pages 550-559
Publisher
Springer Nature
Online
2010-02-25
DOI
10.1038/gt.2010.5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRAIL Gene Therapy: From Preclinical Development to Clinical Application
- (2009) Thomas Griffith et al. CURRENT GENE THERAPY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Multivisceral Resection Does Not Affect Morbidity and Survival After Cytoreductive Surgery and Chemoperfusion for Carcinomatosis from Colorectal Cancer
- (2008) Jan Franko et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice
- (2008) Y Kulu et al. CANCER GENE THERAPY
- Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway
- (2008) S Shamimi-Noori et al. CANCER GENE THERAPY
- JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase
- (2008) W Hu et al. CANCER GENE THERAPY
- Metastasis Suppressor Function of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-R in Mice: Implications for TRAIL-Based Therapy in Humans?
- (2008) A. Grosse-Wilde et al. CANCER RESEARCH
- Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer
- (2008) H. L. Kaufman et al. CLINICAL CANCER RESEARCH
- Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus
- (2008) J Foloppe et al. GENE THERAPY
- A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma
- (2008) E Antonio Chiocca et al. MOLECULAR THERAPY
- The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
- A Herpes Oncolytic Virus Can Be Delivered Via the Vasculature to Produce Biologic Changes in Human Colorectal Cancer
- (2008) Yuman Fong et al. MOLECULAR THERAPY
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- (2008) Roberto Cattaneo et al. NATURE REVIEWS MICROBIOLOGY
- A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma
- (2008) O Ndozangue-Touriguine et al. ONCOGENE
- p53-Mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells
- (2008) F Toscano et al. ONCOGENE
- Diagnosis and Management of Peritoneal Carcinomatosis Arising From Adenocarcinoma of the Colon and Rectum
- (2008) Richard E. Royal et al. SEMINARS IN ONCOLOGY
- Gene transfer: the challenge of regulated gene expression
- (2008) Z. Sheng Guo et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now